The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review.
Giulia FerrarazzoAlberto NieriEmma FirpoAndrea RattaroAlessandro MignoneFlavio GuasoneAugusto ManzaraGiuseppe PerniciaroStefano SpinaciPublished in: Current oncology (Toronto, Ont.) (2023)
Based on these results, we can state that lymphatic mapping with SLNB in cN+ BC patients who become clinically node-negative (ycN0) following NACT is a safe procedure, with a good prognosis and low axillary failure rates.